Comments on:

Who should have say on a patient taking experimental drugs?

Back to the article » By |
Darcy Olsen, president of the Arizona-based Goldwater Institute, and Richard Garr, president of Neuralstem, a biotech company, wrote "Right to Try experimental drugs" in USA Today. They pointed out that "this year, more than 5,000 Americans will lose their battle with ALS, commonly known as Lou Gehrig's disease." Up until recently, there was no medicine on the market that significantly improved...

To learn more about commenting on and our community guidelines, please see our comments FAQ.

More from